Catalina M. Meyer

820 total citations
10 papers, 506 citations indexed

About

Catalina M. Meyer is a scholar working on Molecular Biology, Rheumatology and Genetics. According to data from OpenAlex, Catalina M. Meyer has authored 10 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Rheumatology and 4 papers in Genetics. Recurrent topics in Catalina M. Meyer's work include Glycogen Storage Diseases and Myoclonus (5 papers), Genetics and Neurodevelopmental Disorders (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Catalina M. Meyer is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (5 papers), Genetics and Neurodevelopmental Disorders (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Catalina M. Meyer collaborates with scholars based in United States and Canada. Catalina M. Meyer's co-authors include Peter J. Roach, Anna Depaoli-Roach, Dyann M. Segvich, José M. Irimia, Vincent S. Tagliabracci, Julie Turnbull, Berge A. Minassian, Xiaochu Zhao, Sneha Surendran and Núria Morral and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Diabetes.

In The Last Decade

Catalina M. Meyer

9 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catalina M. Meyer United States 8 277 178 178 177 88 10 506
Dyann M. Segvich United States 13 406 1.5× 217 1.2× 267 1.5× 223 1.3× 127 1.4× 25 639
N Bruni France 6 188 0.7× 172 1.0× 72 0.4× 199 1.1× 7 0.1× 6 422
Aya Abdul-Wahed France 5 85 0.3× 152 0.9× 65 0.4× 221 1.2× 9 0.1× 5 472
R M O'Brien United States 8 96 0.3× 87 0.5× 133 0.7× 286 1.6× 11 0.1× 9 452
Isabelle Houberdon France 4 77 0.3× 135 0.8× 44 0.2× 151 0.9× 9 0.1× 4 320
Catherine Arden United Kingdom 19 53 0.2× 109 0.6× 83 0.5× 418 2.4× 13 0.1× 29 759
Estel Solsona‐Vilarrasa Spain 7 40 0.1× 82 0.5× 31 0.2× 167 0.9× 24 0.3× 13 396
Reza Halse United Kingdom 9 44 0.2× 146 0.8× 37 0.2× 263 1.5× 10 0.1× 10 414
Fabian Klaus Germany 10 55 0.2× 38 0.2× 43 0.2× 296 1.7× 12 0.1× 12 443
W G Strickland United States 11 66 0.2× 112 0.6× 22 0.1× 206 1.2× 15 0.2× 12 419

Countries citing papers authored by Catalina M. Meyer

Since Specialization
Citations

This map shows the geographic impact of Catalina M. Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catalina M. Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catalina M. Meyer more than expected).

Fields of papers citing papers by Catalina M. Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catalina M. Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catalina M. Meyer. The network helps show where Catalina M. Meyer may publish in the future.

Co-authorship network of co-authors of Catalina M. Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Catalina M. Meyer. A scholar is included among the top collaborators of Catalina M. Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catalina M. Meyer. Catalina M. Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Heuer, Josef G., Catalina M. Meyer, Hana E. Baker, et al.. (2022). Pharmacological Evaluation of a Pegylated Urocortin-1 Peptide in Experimental Autoimmune Disease Models. Journal of Pharmacology and Experimental Therapeutics. 382(3). 287–298.
2.
Novosiadly, Ruslan D., David Schaer, Nelusha Amaladas, et al.. (2018). Abstract 4549: Pemetrexed enhances anti-tumor efficacy of PD1 pathway blockade by promoting intra tumor immune response via immunogenic tumor cell death and T cell intrinsic mechanisms. Cancer Research. 78(13_Supplement). 4549–4549. 8 indexed citations
3.
Irimia, José M., Catalina M. Meyer, Dyann M. Segvich, et al.. (2017). Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice. IUScholarWorks (Indiana University). 2 indexed citations
4.
Irimia, José M., Catalina M. Meyer, Dyann M. Segvich, et al.. (2017). Lack of liver glycogen causes hepatic insulin resistance and steatosis in mice. Journal of Biological Chemistry. 292(25). 10455–10464. 74 indexed citations
5.
Irimia, José M., Vincent S. Tagliabracci, Catalina M. Meyer, et al.. (2015). Muscle Glycogen Remodeling and Glycogen Phosphate Metabolism following Exhaustive Exercise of Wild Type and Laforin Knockout Mice. Journal of Biological Chemistry. 290(37). 22686–22698. 20 indexed citations
6.
Depaoli-Roach, Anna, Dyann M. Segvich, Catalina M. Meyer, et al.. (2011). Laforin and malin knockout mice have normal glucose disposal and insulin sensitivity. Human Molecular Genetics. 21(7). 1604–1610. 17 indexed citations
7.
Irimia, José M., Catalina M. Meyer, Lanmin Zhai, et al.. (2010). Impaired Glucose Tolerance and Predisposition to the Fasted State in Liver Glycogen Synthase Knock-out Mice. Journal of Biological Chemistry. 285(17). 12851–12861. 72 indexed citations
8.
Depaoli-Roach, Anna, Vincent S. Tagliabracci, Dyann M. Segvich, et al.. (2010). Genetic Depletion of the Malin E3 Ubiquitin Ligase in Mice Leads to Lafora Bodies and the Accumulation of Insoluble Laforin. Journal of Biological Chemistry. 285(33). 25372–25381. 104 indexed citations
9.
Ramnanan, Christopher J., Dale S. Edgerton, Ben Farmer, et al.. (2010). Molecular Characterization of Insulin-Mediated Suppression of Hepatic Glucose Production In Vivo. Diabetes. 59(6). 1302–1311. 74 indexed citations
10.
Tagliabracci, Vincent S., Dyann M. Segvich, Catalina M. Meyer, et al.. (2008). Abnormal Metabolism of Glycogen Phosphate as a Cause for Lafora Disease. Journal of Biological Chemistry. 283(49). 33816–33825. 135 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026